2013 AAIC Video Highlights
Tuesday, July 16, 2013
"IVIG Phase 3 (GAP) Clinical Trial Results in Alzheimer’s, plus investigations into IVIG’s mechanism of action"
Video 1: News briefing introduction. Dr. Norman Relkin reports additional results and analyses from the negative Phase 3 trial of IVIG in Alzheimer's disease.
Video 2: Dr. Mary Sano discusses the importance of thorough testing of drugs - especially when the drugs are approved for one disease, but being tested for another.
Video 3: IVIG may reduce Alzheimer's-like brain tangles in a mouse model of Alzheimer's disease, according to researcher Dr. Scott Counts.
Video 4: Dr. Debomoy Lahiri talks about the effects of IVIG on oxidative stress in rat brain cells in "test tube" experiments.
Video 5: Q & A with Reporters
Dr. Maria Carrillo of the Alzheimer's Association gives "big picture" perspective on the IVIG Phase 3 results at AAIC 2013.